Nanomedicine

Nanotechnology stems from the ability to probe and control matter at increasingly finer scales. Nanobiosym creates breakthrough scientific insights and revolutionary technologies that emerge from the convergence of physics, nanotechnology, and biomedicine.

Liquidia Technologies is developing engineered particle-based vaccines and therapeutics that have the potential to dramatically improve the quality of human life. Utilizing a novel technology known as the PRINT® platform, Liquidia is creating rationally-design carriers for improved delivery of small molecule and biological cargos.